Ładuje się......
Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis
We herein report the case of a 57-year-old woman presenting with a biopsy-proven tumefactive demyelinating lesion as her first clinical event. Subsequently, she displayed a relapsing-remitting course with recurrence of large demyelinating lesions exceeding 2 cm in diameter rather than the small ovoi...
Zapisane w:
| Wydane w: | Intern Med |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
The Japanese Society of Internal Medicine
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5337470/ https://ncbi.nlm.nih.gov/pubmed/28090055 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|